About HLB LifeScience
HLB LifeScience is a company based in Seongnam-si (South Korea) founded in 1998.. The company has 169 employees as of December 31, 2024. HLB LifeScience has completed 1 acquisition, including AIM. HLB LifeScience operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Seongnam-si, South Korea
- Employees 169 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Hlb Life Science Co.,Ltd.
-
Annual Revenue
$69.33 M (USD)4.34as on Dec 31, 2024
-
Net Profit
$4.16 M (USD)202.68as on Dec 31, 2024
-
EBITDA
$-10.25 M (USD)15.12as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
169
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of HLB LifeScience
HLB LifeScience is a publicly listed company on the KRX with ticker symbol 067630 in South Korea, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of HLB LifeScience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by HLB LifeScience
HLB LifeScience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AIM. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Automated wealth management is delivered via mobile robo-advisor app.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - HLB LifeScience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hlb Lifescience Comparisons
Competitors of HLB LifeScience
HLB LifeScience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Hlb Lifescience
Frequently Asked Questions about HLB LifeScience
When was HLB LifeScience founded?
HLB LifeScience was founded in 1998.
Where is HLB LifeScience located?
HLB LifeScience is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
Who is the current CEO of HLB LifeScience?
Yang Gon Jin is the current CEO of HLB LifeScience.
How many employees does HLB LifeScience have?
As of Dec 31, 2024, the latest employee count at HLB LifeScience is 169.
What is the annual revenue of HLB LifeScience?
Annual revenue of HLB LifeScience is $69.33M as on Dec 31, 2024.
What does HLB LifeScience do?
Founded in 1998 and based in Seongnam-si, South Korea, therapeutics for oncology are developed by HLB LifeScience in the biopharmaceutical sector. Focus is placed on treatments such as Rivoceranib for stomach and liver cancers, Pyrotinib for non-small cell lung cancer, and other anticancer agents. Operations center on research and development to address various cancer types through targeted drug innovations.
Who are the top competitors of HLB LifeScience?
HLB LifeScience's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Is HLB LifeScience publicly traded?
Yes, HLB LifeScience is publicly traded on KRX under the ticker symbol 067630.
How many acquisitions has HLB LifeScience made?
HLB LifeScience has made 1 acquisition, including AIM.
What is HLB LifeScience's ticker symbol?
The ticker symbol of HLB LifeScience is 067630 on KRX.